Cytek Biosciences Inc (CTKB) support and resistance · rev $92.3M
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
This page maps Cytek Biosciences Inc (CTKB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
CTKB currently screens at market cap $421.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CTKB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CTKB quote page for the session range and the stock page for the full model.
Not investment advice.